According to this latest study, the 2021 growth of Subcutaneous Biologics will have significant change from previous year. By the most conservative estimates of global Subcutaneous Biologics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Subcutaneous Biologics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Biologics market by product type, application, key players and key regions and countries.

Segmentation by delivery system: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Syringe

Wearable injector

Automatic injector

Implants

Segmentation by distribution channel: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Hospital pharmacies

Retail pharmacies

Drug stores

Online pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Abbott Laboratories

Pfizer Inc.

Genentech Inc.

Novartis AG

Biogen Idec

AbbVie Inc.

F. Hoffmann-La Roche AG

Bristol-Myers Squibb

Eisai Inc.

Takeda Pharmaceuticals Ltd.

Alnylam Pharmaceuticals

Bayer AG

GlaxoSmithKline

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Subcutaneous Biologics Market Size 2016-2026

2.1.2 Subcutaneous Biologics Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Subcutaneous Biologics Segment by Delivery System

2.2.1 Syringe

2.2.2 Syringe

2.2.3 Automatic injector

2.2.4 Implants

2.3 Subcutaneous Biologics Market Size by Delivery System

2.3.1 Global Subcutaneous Biologics Market Size CAGR by Delivery System

2.3.2 Global Subcutaneous Biologics Market Size Market Share by Delivery System (2016-2021)

2.4 Subcutaneous Biologics Segment by Distribution Channel

2.4.1 Hospital pharmacies

2.4.2 Retail pharmacies

2.4.3 Drug stores

2.4.4 Online pharmacies

2.5 Subcutaneous Biologics Market Size by Distribution Channel

2.5.1 Global Subcutaneous Biologics Market Size CAGR by Distribution Channel

2.5.2 Global Subcutaneous Biologics Market Size Market Share by Distribution Channel (2016-2021)

3 Subcutaneous Biologics Market Size by Players

3.1 Subcutaneous Biologics Market Size Market Share by Players

3.1.1 Global Subcutaneous Biologics Revenue by Players (2019-2021E)

3.1.2 Global Subcutaneous Biologics Revenue Market Share by Players (2019-2021E)

3.2 Global Subcutaneous Biologics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Subcutaneous Biologics by Regions

4.1 Subcutaneous Biologics Market Size by Regions (2016-2021)

4.2 Americas Subcutaneous Biologics Market Size Growth (2016-2021)

4.3 APAC Subcutaneous Biologics Market Size Growth (2016-2021)

4.4 Europe Subcutaneous Biologics Market Size Growth (2016-2021)

4.5 Middle East & Africa Subcutaneous Biologics Market Size Growth (2016-2021)

5 Americas

5.1 Americas Subcutaneous Biologics Market Size by Country (2016-2021)

5.2 Americas Subcutaneous Biologics Market Size by Delivery System (2016-2021)

5.3 Americas Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Subcutaneous Biologics Market Size by Region (2016-2021)

6.2 APAC Subcutaneous Biologics Market Size by Delivery System (2016-2021)

6.3 APAC Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Subcutaneous Biologics by Country (2016-2021)

7.2 Europe Subcutaneous Biologics Market Size by Delivery System (2016-2021)

7.3 Europe Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Subcutaneous Biologics by Region (2016-2021)

8.2 Middle East & Africa Subcutaneous Biologics Market Size by Delivery System (2016-2021)

8.3 Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Subcutaneous Biologics Market Forecast

10.1 Global Subcutaneous Biologics Forecast by Regions (2021-2026)

10.1.1 Global Subcutaneous Biologics Forecast by Regions (2021-2026)

10.1.2 Americas Subcutaneous Biologics Forecast

10.1.3 APAC Subcutaneous Biologics Forecast

10.1.4 Europe Subcutaneous Biologics Forecast

10.1.5 Middle East & Africa Subcutaneous Biologics Forecast

10.2 Americas Subcutaneous Biologics Forecast by Countries (2021-2026)

10.2.1 United States Subcutaneous Biologics Market Forecast

10.2.2 Canada Subcutaneous Biologics Market Forecast

10.2.3 Mexico Subcutaneous Biologics Market Forecast

10.2.4 Brazil Subcutaneous Biologics Market Forecast

10.3 APAC Subcutaneous Biologics Forecast by Region (2021-2026)

10.3.1 China Subcutaneous Biologics Market Forecast

10.3.2 Japan Subcutaneous Biologics Market Forecast

10.3.3 Korea Subcutaneous Biologics Market Forecast

10.3.4 Southeast Asia Subcutaneous Biologics Market Forecast

10.3.5 India Subcutaneous Biologics Market Forecast

10.3.6 Australia Subcutaneous Biologics Market Forecast

10.4 Europe Subcutaneous Biologics Forecast by Country (2021-2026)

10.4.1 Germany Subcutaneous Biologics Market Forecast

10.4.2 France Subcutaneous Biologics Market Forecast

10.4.3 UK Subcutaneous Biologics Market Forecast

10.4.4 Italy Subcutaneous Biologics Market Forecast

10.4.5 Russia Subcutaneous Biologics Market Forecast

10.5 Middle East & Africa Subcutaneous Biologics Forecast by Region (2021-2026)

10.5.1 Egypt Subcutaneous Biologics Market Forecast

10.5.2 South Africa Subcutaneous Biologics Market Forecast

10.5.3 Israel Subcutaneous Biologics Market Forecast

10.5.4 Turkey Subcutaneous Biologics Market Forecast

10.5.5 GCC Countries Subcutaneous Biologics Market Forecast

10.6 Global Subcutaneous Biologics Forecast by Delivery System (2021-2026)

10.8 Global Subcutaneous Biologics Forecast by Distribution Channel (2021-2026)

11 Key Players Analysis

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Information

11.1.2 Abbott Laboratories Subcutaneous Biologics Product Offered

11.1.3 Abbott Laboratories Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Abbott Laboratories Main Business Overview

11.1.5 Abbott Laboratories Latest Developments

11.2 Pfizer Inc.

11.2.1 Pfizer Inc. Company Information

11.2.2 Pfizer Inc. Subcutaneous Biologics Product Offered

11.2.3 Pfizer Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Pfizer Inc. Main Business Overview

11.2.5 Pfizer Inc. Latest Developments

11.3 Genentech Inc.

11.3.1 Genentech Inc. Company Information

11.3.2 Genentech Inc. Subcutaneous Biologics Product Offered

11.3.3 Genentech Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Genentech Inc. Main Business Overview

11.3.5 Genentech Inc. Latest Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Information

11.4.2 Novartis AG Subcutaneous Biologics Product Offered

11.4.3 Novartis AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Novartis AG Main Business Overview

11.4.5 Novartis AG Latest Developments

11.5 Biogen Idec

11.5.1 Biogen Idec Company Information

11.5.2 Biogen Idec Subcutaneous Biologics Product Offered

11.5.3 Biogen Idec Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Biogen Idec Main Business Overview

11.5.5 Biogen Idec Latest Developments

11.6 AbbVie Inc.

11.6.1 AbbVie Inc. Company Information

11.6.2 AbbVie Inc. Subcutaneous Biologics Product Offered

11.6.3 AbbVie Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 AbbVie Inc. Main Business Overview

11.6.5 AbbVie Inc. Latest Developments

11.7 F. Hoffmann-La Roche AG

11.7.1 F. Hoffmann-La Roche AG Company Information

11.7.2 F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offered

11.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 F. Hoffmann-La Roche AG Main Business Overview

11.7.5 F. Hoffmann-La Roche AG Latest Developments

11.8 Bristol-Myers Squibb

11.8.1 Bristol-Myers Squibb Company Information

11.8.2 Bristol-Myers Squibb Subcutaneous Biologics Product Offered

11.8.3 Bristol-Myers Squibb Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Bristol-Myers Squibb Main Business Overview

11.8.5 Bristol-Myers Squibb Latest Developments

11.9 Eisai Inc.

11.9.1 Eisai Inc. Company Information

11.9.2 Eisai Inc. Subcutaneous Biologics Product Offered

11.9.3 Eisai Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Eisai Inc. Main Business Overview

11.9.5 Eisai Inc. Latest Developments

11.10 Takeda Pharmaceuticals Ltd.

11.10.1 Takeda Pharmaceuticals Ltd. Company Information

11.10.2 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offered

11.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Takeda Pharmaceuticals Ltd. Main Business Overview

11.10.5 Takeda Pharmaceuticals Ltd. Latest Developments

11. Alnylam Pharmaceuticals

11.11.1 Alnylam Pharmaceuticals Company Information

11.11.2 Alnylam Pharmaceuticals Subcutaneous Biologics Product Offered

11.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Alnylam Pharmaceuticals Main Business Overview

11.11.5 Alnylam Pharmaceuticals Latest Developments

11.12 Bayer AG

11.12.1 Bayer AG Company Information

11.12.2 Bayer AG Subcutaneous Biologics Product Offered

11.12.3 Bayer AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Bayer AG Main Business Overview

11.12.5 Bayer AG Latest Developments

11.13 GlaxoSmithKline

11.13.1 GlaxoSmithKline Company Information

11.13.2 GlaxoSmithKline Subcutaneous Biologics Product Offered

11.13.3 GlaxoSmithKline Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 GlaxoSmithKline Main Business Overview

11.13.5 GlaxoSmithKline Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Subcutaneous Biologics Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Syringe

Table 3. Major Players of Wearable injector

Table 4. Major Players of Automatic injector

Table 5. Major Players of Implants

Table 6. Subcutaneous Biologics Market Size CAGR by Delivery System (2020-2026) & ($ Millions)

Table 7. Global Subcutaneous Biologics Market Size by Delivery System (2016-2021) & ($ Millions)

Table 8. Global Subcutaneous Biologics Market Size Market Share by Delivery System (2016-2021)

Table 9. Subcutaneous Biologics Market Size CAGR by Distribution Channel (2016-2021) & ($ Millions)

Table 10. Global Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) & ($ Millions)

Table 11. Global Subcutaneous Biologics Market Size Market Share by Distribution Channel (2016-2021)

Table 12. Global Subcutaneous Biologics Revenue by Players (2019-2021E) & ($ Millions)

Table 13. Global Subcutaneous Biologics Revenue Market Share by Players (2019-2021E)

Table 14. Subcutaneous Biologics Key Players Head office and Products Offered

Table 15. Subcutaneous Biologics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Subcutaneous Biologics Market Size by Regions 2016-2021 & ($ Millions)

Table 19. Global Subcutaneous Biologics Market Size Market Share by Regions 2016-2021

Table 20. Americas Subcutaneous Biologics Market Size by Country (2016-2021) & ($ Millions)

Table 21. Americas Subcutaneous Biologics Market Size Market Share by Country (2016-2021)

Table 22. Americas Subcutaneous Biologics Market Size by Delivery System (2016-2021) & ($ Millions)

Table 23. Americas Subcutaneous Biologics Market Size Market Share by Delivery System (2016-2021)

Table 24. Americas Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) & ($ Millions)

Table 25. Americas Subcutaneous Biologics Market Size Market Share by Distribution Channel (2016-2021)

Table 26. APAC Subcutaneous Biologics Market Size by Region (2016-2021) & ($ Millions)

Table 27. APAC Subcutaneous Biologics Market Size Market Share by Region (2016-2021)

Table 28. APAC Subcutaneous Biologics Market Size by Delivery System (2016-2021) & ($ Millions)

Table 29. APAC Subcutaneous Biologics Market Size Market Share by Delivery System (2016-2021)

Table 30. APAC Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) & ($ Millions)

Table 31. APAC Subcutaneous Biologics Market Size Market Share by Distribution Channel (2016-2021)

Table 32. Europe Subcutaneous Biologics Market Size by Country (2016-2021) & ($ Millions)

Table 33. Europe Subcutaneous Biologics Market Size Market Share by Country (2016-2021)

Table 34. Europe Subcutaneous Biologics Market Size by Delivery System (2016-2021) & ($ Millions)

Table 35. Europe Subcutaneous Biologics Market Size Market Share by Delivery System (2016-2021)

Table 36. Europe Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) & ($ Millions)

Table 37. Europe Subcutaneous Biologics Market Size Market Share by Distribution Channel (2016-2021)

Table 38. Middle East & Africa Subcutaneous Biologics Market Size by Region (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Region (2016-2021)

Table 40. Middle East & Africa Subcutaneous Biologics Market Size by Delivery System (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Delivery System (2016-2021)

Table 42. Middle East & Africa Subcutaneous Biologics Market Size by Distribution Channel (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Distribution Channel (2016-2021)

Table 44. Key and Potential Regions of Subcutaneous Biologics

Table 45. Key Application and Potential Industries of Subcutaneous Biologics

Table 46. Key Challenges of Subcutaneous Biologics

Table 47. Key Trends of Subcutaneous Biologics

Table 48. Global Subcutaneous Biologics Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 49. Global Subcutaneous Biologics Market Size Market Share Forecast by Regions (2021-2026)

Table 50. Global Subcutaneous Biologics Market Size Forecast by Delivery System (2021-2026) & ($ Millions)

Table 51. Global Subcutaneous Biologics Market Size Market Share Forecast by Delivery System (2021-2026)

Table 52. Global Subcutaneous Biologics Market Size Forecast by Distribution Channel (2021-2026) & ($ Millions)

Table 53. Global Subcutaneous Biologics Market Size Market Share Forecast by Distribution Channel (2021-2026)

Table 54. Abbott Laboratories Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 55. Abbott Laboratories Subcutaneous Biologics Product Offered

Table 56. Abbott Laboratories Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 57. Abbott Laboratories Main Business

Table 58. Abbott Laboratories Latest Developments

Table 59. Pfizer Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 60. Pfizer Inc. Subcutaneous Biologics Product Offered

Table 61. Pfizer Inc. Main Business

Table 62. Pfizer Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. Pfizer Inc. Latest Developments

Table 64. Genentech Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 65. Genentech Inc. Subcutaneous Biologics Product Offered

Table 66. Genentech Inc. Main Business

Table 67. Genentech Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 68. Genentech Inc. Latest Developments

Table 69. Novartis AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 70. Novartis AG Subcutaneous Biologics Product Offered

Table 71. Novartis AG Main Business

Table 72. Novartis AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 73. Novartis AG Latest Developments

Table 74. Biogen Idec Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 75. Biogen Idec Subcutaneous Biologics Product Offered

Table 76. Biogen Idec Main Business

Table 77. Biogen Idec Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 78. Biogen Idec Latest Developments

Table 79. AbbVie Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 80. AbbVie Inc. Subcutaneous Biologics Product Offered

Table 81. AbbVie Inc. Main Business

Table 82. AbbVie Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 83. AbbVie Inc. Latest Developments

Table 84. F. Hoffmann-La Roche AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 85. F. Hoffmann-La Roche AG Subcutaneous Biologics Product Offered

Table 86. F. Hoffmann-La Roche AG Main Business

Table 87. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 88. F. Hoffmann-La Roche AG Latest Developments

Table 89. Bristol-Myers Squibb Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 90. Bristol-Myers Squibb Subcutaneous Biologics Product Offered

Table 91. Bristol-Myers Squibb Main Business

Table 92. Bristol-Myers Squibb Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 93. Bristol-Myers Squibb Latest Developments

Table 94. Eisai Inc. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 95. Eisai Inc. Subcutaneous Biologics Product Offered

Table 96. Eisai Inc. Main Business

Table 97. Eisai Inc. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 98. Eisai Inc. Latest Developments

Table 99. Takeda Pharmaceuticals Ltd. Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 100. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product Offered

Table 101. Takeda Pharmaceuticals Ltd. Main Business

Table 102. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 103. Takeda Pharmaceuticals Ltd. Latest Developments

Table 104. Alnylam Pharmaceuticals Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 105. Alnylam Pharmaceuticals Subcutaneous Biologics Product Offered

Table 106. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 107. Alnylam Pharmaceuticals Main Business

Table 108. Alnylam Pharmaceuticals Latest Developments

Table 109. Bayer AG Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 110. Bayer AG Subcutaneous Biologics Product Offered

Table 111. Bayer AG Main Business

Table 112. Bayer AG Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 113. Bayer AG Latest Developments

Table 114. GlaxoSmithKline Details, Company Type, Subcutaneous Biologics Area Served and Its Competitors

Table 115. GlaxoSmithKline Subcutaneous Biologics Product Offered

Table 116. GlaxoSmithKline Main Business

Table 117. GlaxoSmithKline Subcutaneous Biologics Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 118. GlaxoSmithKline Latest Developments

List of Figures

Figure 1. Subcutaneous Biologics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Subcutaneous Biologics Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Subcutaneous Biologics Market Size Market Share by Delivery System in 2020

Figure 7. Subcutaneous Biologics in Hospital pharmacies

Figure 8. Global Subcutaneous Biologics Market: Hospital pharmacies (2016-2021) & ($ Millions)

Figure 9. Subcutaneous Biologics in Retail pharmacies

Figure 10. Global Subcutaneous Biologics Market: Retail pharmacies (2016-2021) & ($ Millions)

Figure 11. Subcutaneous Biologics in Drug stores

Figure 12. Global Subcutaneous Biologics Market: Drug stores (2016-2021) & ($ Millions)

Figure 13. Subcutaneous Biologics in Online pharmacies

Figure 14. Global Subcutaneous Biologics Market: Online pharmacies (2016-2021) & ($ Millions)

Figure 15. Global Subcutaneous Biologics Market Size Market Share by Distribution Channel in 2020

Figure 16. Global Subcutaneous Biologics Revenue Market Share by Player in 2020

Figure 17. Global Subcutaneous Biologics Market Size Market Share by Regions (2016-2021)

Figure 18. Americas Subcutaneous Biologics Market Size 2016-2021 ($ Millions)

Figure 19. APAC Subcutaneous Biologics Market Size 2016-2021 ($ Millions)

Figure 20. Europe Subcutaneous Biologics Market Size 2016-2021 ($ Millions)

Figure 21. Middle East & Africa Subcutaneous Biologics Market Size 2016-2021 ($ Millions)

Figure 22. Americas Subcutaneous Biologics Market Size Market Share by Country in 2020

Figure 23. Americas Subcutaneous Biologics Market Size Market Share by Delivery System in 2020

Figure 24. Americas Subcutaneous Biologics Market Size Market Share by Distribution Channel in 2020

Figure 25. United States Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 26. Canada Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 27. Mexico Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 28. APAC Subcutaneous Biologics Market Size Market Share by Regions in 2020

Figure 29. APAC Subcutaneous Biologics Market Size Market Share by Delivery System in 2020

Figure 30. APAC Subcutaneous Biologics Market Size Market Share by Distribution Channel in 2020

Figure 31. China Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 32. Japan Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 33. Korea Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 34. Southeast Asia Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 35. India Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 36. Australia Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 37. Europe Subcutaneous Biologics Market Size Market Share by Country in 2020

Figure 38. Europe Subcutaneous Biologics Market Size Market Share by Delivery System in 2020

Figure 39. Europe Subcutaneous Biologics Market Size Market Share by Distribution Channel in 2020

Figure 40. Germany Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 41. France Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 42. UK Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 43. Italy Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 44. Russia Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 45. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Region in 2020

Figure 46. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Delivery System in 2020

Figure 47. Middle East & Africa Subcutaneous Biologics Market Size Market Share by Distribution Channel in 2020

Figure 48. Egypt Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 49. South Africa Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 50. Israel Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 51. Turkey Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 52. GCC Country Subcutaneous Biologics Market Size Growth 2016-2021 ($ Millions)

Figure 53. Americas Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 54. APAC Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 55. Europe Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 56. Middle East & Africa Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 57. United States Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 58. Canada Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 59. Mexico Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 60. Brazil Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 61. China Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 62. Japan Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 63. Korea Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 64. Southeast Asia Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 65. India Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 66. Australia Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 67. Germany Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 68. France Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 69. UK Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 70. Italy Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 71. Russia Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 72. Spain Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 73. Egypt Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 74. South Africa Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 75. Israel Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 76. Turkey Subcutaneous Biologics Market Size 2021-2026 ($ Millions)

Figure 77. GCC Country Subcutaneous Biologics Market Size 2021-2026 ($ Millions)